Cargando…

Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer

BACKGROUND: Local tumour destruction has been shown to give rise to changes in immunocompetent cells. The aim of this study was to describe the effect of interstitial laser thermotherapy (ILT) of breast carcinoma in the tumour and in regional lymph nodes. METHODS: Seventeen women that underwent radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraldsdóttir, Kristin H., Ivarsson, Kjell, Jansner, Karin, Stenram, Unne, Tranberg, Karl-G.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098997/
https://www.ncbi.nlm.nih.gov/pubmed/21400025
http://dx.doi.org/10.1007/s00262-011-0992-8
_version_ 1782204022659219456
author Haraldsdóttir, Kristin H.
Ivarsson, Kjell
Jansner, Karin
Stenram, Unne
Tranberg, Karl-G.
author_facet Haraldsdóttir, Kristin H.
Ivarsson, Kjell
Jansner, Karin
Stenram, Unne
Tranberg, Karl-G.
author_sort Haraldsdóttir, Kristin H.
collection PubMed
description BACKGROUND: Local tumour destruction has been shown to give rise to changes in immunocompetent cells. The aim of this study was to describe the effect of interstitial laser thermotherapy (ILT) of breast carcinoma in the tumour and in regional lymph nodes. METHODS: Seventeen women that underwent radical surgical excision after non-radical ILT were studied. ILT was performed at a steady-state temperature of 48°C for 30 min. Surgical excision was performed 12 (6–23) days after ILT. Six patients with breast cancer not treated with ILT before surgery served as controls. Immunohistological reactions were performed on core needle biopsies prior to treatment and on the excised specimens. RESULTS: ILT resulted in more CD8 lymphocytes and CD68 macrophages within the tumour (P < 0.05 and P < 0.01, respectively) and higher counts of CD20 (P < 0.05), CD68 (P < 0.001) and CD83 (P < 0.01) at the tumour border, when compared to pre-treatment values. In the control patients not receiving ILT, CD8 cells increased within the tumour after resection (P < 0.05). With the probable exception of CD25 Foxp3 cells, the presence of cancer in a lymph node influenced the findings in lymph nodes (examined for CD1a, CD25, Foxp3 CD25, CD83 cells). Thus, comparisons between ILT and control patients were restricted to patients without lymph node metastases. In these patients, ILT and resection were followed by a decrease in CD25 Foxp3 lymphocytes (P < 0.05), when compared to surgical resection alone. CONCLUSIONS: ILT induced changes in immunocompetent cells in patients with breast cancer. The stimulation of the immune system is an added feature of ILT in treatment of patients with breast cancer.
format Text
id pubmed-3098997
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30989972011-07-14 Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer Haraldsdóttir, Kristin H. Ivarsson, Kjell Jansner, Karin Stenram, Unne Tranberg, Karl-G. Cancer Immunol Immunother Original Article BACKGROUND: Local tumour destruction has been shown to give rise to changes in immunocompetent cells. The aim of this study was to describe the effect of interstitial laser thermotherapy (ILT) of breast carcinoma in the tumour and in regional lymph nodes. METHODS: Seventeen women that underwent radical surgical excision after non-radical ILT were studied. ILT was performed at a steady-state temperature of 48°C for 30 min. Surgical excision was performed 12 (6–23) days after ILT. Six patients with breast cancer not treated with ILT before surgery served as controls. Immunohistological reactions were performed on core needle biopsies prior to treatment and on the excised specimens. RESULTS: ILT resulted in more CD8 lymphocytes and CD68 macrophages within the tumour (P < 0.05 and P < 0.01, respectively) and higher counts of CD20 (P < 0.05), CD68 (P < 0.001) and CD83 (P < 0.01) at the tumour border, when compared to pre-treatment values. In the control patients not receiving ILT, CD8 cells increased within the tumour after resection (P < 0.05). With the probable exception of CD25 Foxp3 cells, the presence of cancer in a lymph node influenced the findings in lymph nodes (examined for CD1a, CD25, Foxp3 CD25, CD83 cells). Thus, comparisons between ILT and control patients were restricted to patients without lymph node metastases. In these patients, ILT and resection were followed by a decrease in CD25 Foxp3 lymphocytes (P < 0.05), when compared to surgical resection alone. CONCLUSIONS: ILT induced changes in immunocompetent cells in patients with breast cancer. The stimulation of the immune system is an added feature of ILT in treatment of patients with breast cancer. Springer-Verlag 2011-03-13 2011 /pmc/articles/PMC3098997/ /pubmed/21400025 http://dx.doi.org/10.1007/s00262-011-0992-8 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Haraldsdóttir, Kristin H.
Ivarsson, Kjell
Jansner, Karin
Stenram, Unne
Tranberg, Karl-G.
Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title_full Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title_fullStr Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title_full_unstemmed Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title_short Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
title_sort changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098997/
https://www.ncbi.nlm.nih.gov/pubmed/21400025
http://dx.doi.org/10.1007/s00262-011-0992-8
work_keys_str_mv AT haraldsdottirkristinh changesinimmunocompetentcellsafterinterstitiallaserthermotherapyofbreastcancer
AT ivarssonkjell changesinimmunocompetentcellsafterinterstitiallaserthermotherapyofbreastcancer
AT jansnerkarin changesinimmunocompetentcellsafterinterstitiallaserthermotherapyofbreastcancer
AT stenramunne changesinimmunocompetentcellsafterinterstitiallaserthermotherapyofbreastcancer
AT tranbergkarlg changesinimmunocompetentcellsafterinterstitiallaserthermotherapyofbreastcancer